60 related articles for article (PubMed ID: 28766133)
1. Prognostic significance of neutrophil-lymphocyte ratios in large cell neuroendocrine carcinoma.
Okui M; Yamamichi T; Asakawa A; Harada M; Saito M; Horio H
Gen Thorac Cardiovasc Surg; 2017 Nov; 65(11):633-639. PubMed ID: 28766133
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and nomogram for pulmonary resected high-grade neuroendocrine carcinomas: a 20-year single institutional real-world experience.
Liu L; Zhang J; Zhao K; Guo C; Huang C; Li S; Chen Y
Orphanet J Rare Dis; 2024 Jun; 19(1):232. PubMed ID: 38863016
[TBL] [Abstract][Full Text] [Related]
3. Pretreament neutrophil-lymphocyte ratio (NLR): A felicitous prognostic marker in carcinoma lung.
Sehgal SA; Malik G; Sachdeva A; Chauhan AK; Kaushal V; Kaur P; Atri R
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S719-S723. PubMed ID: 38384045
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study.
Wang Y; Zhuang J; Wang S; Wu Y; Chen L
PeerJ; 2024; 12():e17382. PubMed ID: 38766483
[TBL] [Abstract][Full Text] [Related]
5. An unexpected case of large cell neuroendocrine carcinoma of the colon: a case report.
Nnawuba K; Travis D; Jensen H; Lockwood B
J Gastrointest Oncol; 2024 Feb; 15(1):508-513. PubMed ID: 38482252
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma: A Retrospective Cohort Study.
Chang L; Zhang X; Li J; Li Q
Am J Clin Oncol; 2024 Apr; ():. PubMed ID: 38629640
[TBL] [Abstract][Full Text] [Related]
7. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma.
Zhu S; Wang X; Li H; Zhao P; Liu J; Zhang L; Cheng Y
Front Med (Lausanne); 2024; 11():1326426. PubMed ID: 38482526
[TBL] [Abstract][Full Text] [Related]
8. Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study.
Akdag G; Alan Ö; Dogan A; Yildirim S; Kinikoglu O; Batu A; Kudu E; Geçmen GG; Isik D; Sever ON; Odabas H; Yildirim ME; Turan N
Heliyon; 2024 Feb; 10(3):e25029. PubMed ID: 38317875
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio is a negative prognostic biomarker for luminal A breast cancer.
Xiang Y; Zhang N; Lei H; Wu J; Wang W; Zhang H; Zeng X
Gland Surg; 2023 Mar; 12(3):415-425. PubMed ID: 37057046
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative C-reactive protein to albumin ratio in non-small cell lung cancer patients: A meta-analysis.
He D; Yang Y; Yang Y; Tang X; Huang K
Front Surg; 2022; 9():1056795. PubMed ID: 36684183
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract][Full Text] [Related]
13. Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Giannetta E; La Salvia A; Rizza L; Muscogiuri G; Campione S; Pozza C; Colao AAL; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():672499. PubMed ID: 34367064
[TBL] [Abstract][Full Text] [Related]
14. Serum Inflammation-based Scores in Endocrine Tumors.
Marques P; de Vries F; Dekkers OM; Korbonits M; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3796-e3819. PubMed ID: 33837783
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review.
Chen Y; Zhang J; Huang C; Tian Z; Zhou X; Guo C; Liu H; Li S
Orphanet J Rare Dis; 2021 Feb; 16(1):82. PubMed ID: 33579331
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative serum inflammation-based scores in patients with pituitary adenomas.
Marques P; de Vries F; Dekkers OM; van Furth WR; Korbonits M; Biermasz NR; Pereira AM
Pituitary; 2021 Jun; 24(3):334-350. PubMed ID: 33230695
[TBL] [Abstract][Full Text] [Related]
17. [Advances in Molecular Biomarker for Pulmonary Large Cell Neuroendocrine Carcinoma].
Zhang J; Yang L; Li J
Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):983-988. PubMed ID: 33203199
[TBL] [Abstract][Full Text] [Related]
18. Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
Galvano A; Peri M; Guarini AA; Castiglia M; Grassadonia A; De Tursi M; Irtelli L; Rizzo S; Bertani A; Gristina V; Barraco N; Russo A; Natoli C; Bazan V
Ther Adv Med Oncol; 2020; 12():1758835920942378. PubMed ID: 32849916
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value Of The Preoperative Neutrophil To Lymphocyte Ratio In Patients With Sinonasal Squamous Cell Carcinoma.
Zhong B; Deng D; Du JT; Chen F; Liu YF; Liu SX
Cancer Manag Res; 2019; 11():9733-9741. PubMed ID: 31814768
[TBL] [Abstract][Full Text] [Related]
20. The prognostic nutritional index in resected high-grade pulmonary neuroendocrine carcinoma.
Okui M; Horio H; Asakawa A; Yamamichi T; Harada M
Gen Thorac Cardiovasc Surg; 2020 Jan; 68(1):43-48. PubMed ID: 31190180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
